UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance

Endocrinology (Philadelphia), 2013-03, Vol.154 (3), p.1021-1028

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

Proceedings of the National Academy of Sciences - PNAS, 2011-04, Vol.108 (14), p.5748-5752

2011

Link zum Volltext

Verfügbarkeit prüfen

ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content

Journal of lipid research, 2015-03, Vol.56 (3), p.526-536

2015

Link zum Volltext

Verfügbarkeit prüfen

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator–Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models

Journal of Pharmacological Sciences, 2009, Vol.111(2), pp.155-166

2009

Link zum Volltext

Verfügbarkeit prüfen

Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice

Diabetologia, 2014-06, Vol.57 (6), p.1232-1241

2014

Link zum Volltext

Verfügbarkeit prüfen

Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats

Journal of Pharmacological Sciences, 2011, Vol.115(3), pp.329-335

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor γ Ligand, Cerco-A

Biological and Pharmaceutical Bulletin, 2011/07/01, Vol.34(7), pp.1094-1104

2011

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein CIII overexpressing mice are predisposed to diet‐induced hepatic steatosis and hepatic insulin resistance

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1650-1660

2011

Link zum Volltext

Verfügbarkeit prüfen

Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 2013-05, Vol.23 (9), p.2560-2565

2013

Link zum Volltext

Verfügbarkeit prüfen

Second‐generation antisense oligonucleotides against β‐catenin protect mice against diet‐induced hepatic steatosis and hepatic and peripheral insulin resistance

The FASEB journal, 2016-03, Vol.30 (3), p.1207-1217

2016

Link zum Volltext

Verfügbarkeit prüfen

Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitors

Bioorganic & medicinal chemistry letters, 2012-08, Vol.22 (15), p.5067-5070

2012

Link zum Volltext

Verfügbarkeit prüfen

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats

European journal of pharmacology, 2009-11, Vol.623 (1), p.141-147

2009

Link zum Volltext

Verfügbarkeit prüfen

Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice

Diabetologia, 2014-06, Vol.57 (6), p.1232-1241

2014

Link zum Volltext

Verfügbarkeit prüfen

Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels

European journal of pharmacology, 1998-10, Vol.358 (3), p.277-287

1998

Link zum Volltext

Verfügbarkeit prüfen

Muscle-specific activation of Ca^sup 2+^/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice

Diabetologia, 2014-06, Vol.57 (6), p.1232

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor [gamma] Ligand, Cerco-A

Biological & pharmaceutical bulletin, 2011-07, Vol.34 (7), p.1094

2011

Link zum Volltext

Verfügbarkeit prüfen

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator―Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models

Journal of Pharmacological Sciences, 2009-10, Vol.111 (2), p.155-166

2009

Link zum Volltext

Verfügbarkeit prüfen

Diltiazem derivatives modulate the dihydropyridine-binding to intact rat ventricular myocytes

European journal of pharmacology, 1997-01, Vol.319 (1), p.101-107

1997

Link zum Volltext

Verfügbarkeit prüfen

Effects of diltiazem derivatives on the specific binding of (+)-[^^3 H]PN200-110 to isolated rat ventricular myocytes

Japanese Journal of Pharmacology, 1996, Vol.71 (suppl.1), p.66-66

1996

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Sodium Liothyronine in Tablets

Chemical and Pharmaceutical Bulletin, 1982/05/25, Vol.30(5), pp.1747-1752

1982

Link zum Volltext

Verfügbarkeit prüfen

Tissue specific expression of splice variants of the L-type Ca2+ channel α1C subunit in rats

Japanese journal of pharmacology, 2000, Vol.82, p.82

2000

Link zum Volltext

Verfügbarkeit prüfen

O-161 - Tissue specific expression of splice variants of the L-type Ca2+ channel α1C subunit in rats

Japanese journal of pharmacology, 2000, Vol.82, p.82-82

2000

Link zum Volltext

Verfügbarkeit prüfen

Tissue specific expression of splice variants of the L-type Ca2+ channel α_1C subunit in rats

Japanese Journal of Pharmacology, 2000, Vol.82 (suppl.1), p.82-82

2000

Link zum Volltext

Verfügbarkeit prüfen

Functional allosteric interaction between diltiazem and dihydropyridine sites of the cardiac L-type Ca2+ channel

Japanese Journal of Pharmacology, 1997, Vol.73 (suppl.1), p.82-82

1997

Link zum Volltext

Verfügbarkeit prüfen

Functional allosteric interaction between diltiazem and dihydropyridlne sites of the cardiac L-type Ca2+ channel

Japanese journal of pharmacology, 1997, Vol.73, p.82-82

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(80)
Tagungsberichte
(5)

Sprache

Englisch
(71)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(35)
Male
(24)
Animals
(23)
Humans
(18)
Female
(16)
Biological And Medical Sciences
(15)
Pharmacology & Pharmacy
(13)
Mice
(12)
Rats
(12)
Middle Aged
(9)
Insulin Resistance
(8)
Medical Sciences
(8)
Patients
(8)
Aged
(7)
Biochemistry & Molecular Biology
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Glucose - Metabolism
(7)
Physical Sciences
(7)
Chemistry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator–Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models

Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice

Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats

Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor γ Ligand, Cerco-A

Apolipoprotein CIII overexpressing mice are predisposed to diet‐induced hepatic steatosis and hepatic insulin resistance

Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties

Second‐generation antisense oligonucleotides against β‐catenin protect mice against diet‐induced hepatic steatosis and hepatic and peripheral insulin resistance

Discovery and optimization of novel fatty acid transport protein 1 (FATP1) inhibitors

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats

Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice

Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels

Muscle-specific activation of Ca^sup 2+^/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice

Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor [gamma] Ligand, Cerco-A

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator―Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models

Diltiazem derivatives modulate the dihydropyridine-binding to intact rat ventricular myocytes

Effects of diltiazem derivatives on the specific binding of (+)-[^^3 H]PN200-110 to isolated rat ventricular myocytes

Analysis of Sodium Liothyronine in Tablets

Tissue specific expression of splice variants of the L-type Ca2+ channel α1C subunit in rats

O-161 - Tissue specific expression of splice variants of the L-type Ca2+ channel α1C subunit in rats

Tissue specific expression of splice variants of the L-type Ca2+ channel α_1C subunit in rats

Functional allosteric interaction between diltiazem and dihydropyridine sites of the cardiac L-type Ca2+ channel

Functional allosteric interaction between diltiazem and dihydropyridlne sites of the cardiac L-type Ca2+ channel

Suchergebnisse filtern